日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Pseudoalteromonas phage PM2 Uncharacterized protein Gp-a (a) CSB-YP894051PTQ
CSB-EP894051PTQ
CSB-BP894051PTQ
CSB-MP894051PTQ
CSB-EP894051PTQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dasyatis laosensis Cytochrome b (mt-cyb), partial CSB-YP894052DEAW
CSB-EP894052DEAW
CSB-BP894052DEAW
CSB-MP894052DEAW
CSB-EP894052DEAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Kluyveromyces lactis Cytochrome c oxidase subunit 3 (COX3), partial CSB-YP894053KBK1
CSB-EP894053KBK1
CSB-BP894053KBK1
CSB-MP894053KBK1
CSB-EP894053KBK1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salvelinus fontinalis ATP synthase protein 8 (mt-atp8), partial CSB-YP894054SBX
CSB-EP894054SBX
CSB-BP894054SBX
CSB-MP894054SBX
CSB-EP894054SBX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Reithrodontomys sumichrasti Cytochrome b (MT-CYB), partial CSB-YP894055REAW
CSB-EP894055REAW
CSB-BP894055REAW
CSB-MP894055REAW
CSB-EP894055REAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sigmodon hispidus Cytochrome b (MT-CYB), partial CSB-YP894056SZK
CSB-EP894056SZK
CSB-BP894056SZK
CSB-MP894056SZK
CSB-EP894056SZK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thomasomys gracilis Cytochrome b (MT-CYB), partial CSB-YP894057THAY
CSB-EP894057THAY
CSB-BP894057THAY
CSB-MP894057THAY
CSB-EP894057THAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Akodon nigrita Cytochrome b (MT-CYB), partial CSB-YP894058AMAJ
CSB-EP894058AMAJ
CSB-BP894058AMAJ
CSB-MP894058AMAJ
CSB-EP894058AMAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sminthopsis griseoventer Cytochrome b (MT-CYB), partial CSB-YP894059SMAU
CSB-EP894059SMAU
CSB-BP894059SMAU
CSB-MP894059SMAU
CSB-EP894059SMAU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helonias bullata Maturase K (matK), partial CSB-YP894060HHAG
CSB-EP894060HHAG
CSB-BP894060HHAG
CSB-MP894060HHAG
CSB-EP894060HHAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Triticum aestivum Uncharacterized protein ycf70 (ycf70) CSB-YP894061TQN
CSB-EP894061TQN
CSB-BP894061TQN
CSB-MP894061TQN
CSB-EP894061TQN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brassica napus NAD (P)H-quinone oxidoreductase subunit 2, chloroplastic (ndhB), partial CSB-YP894062BWD
CSB-EP894062BWD
CSB-BP894062BWD
CSB-MP894062BWD
CSB-EP894062BWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pisum sativum Photosystem II reaction center protein H (psbH), partial CSB-YP894063EWE1
CSB-EP894063EWE1
CSB-BP894063EWE1
CSB-MP894063EWE1
CSB-EP894063EWE1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Heterocapsa triquetra Photosystem I P700 chlorophyll a apoprotein A2 (psaB), partial CSB-YP894064HCAB
CSB-EP894064HCAB
CSB-BP894064HCAB
CSB-MP894064HCAB
CSB-EP894064HCAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Trichosurus vulpecula Interleukin-1 beta (IL1B) CSB-YP894065TQG
CSB-EP894065TQG
CSB-BP894065TQG
CSB-MP894065TQG
CSB-EP894065TQG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine WD repeat-containing protein 44 (WDR44), partial CSB-YP894066BO
CSB-EP894066BO
CSB-BP894066BO
CSB-MP894066BO
CSB-EP894066BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Trichosurus vulpecula Beta-casein (CSN2) CSB-YP894067TQG
CSB-EP894067TQG
CSB-BP894067TQG
CSB-MP894067TQG
CSB-EP894067TQG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saguinus oedipus Peptidyl-prolyl cis-trans isomerase FKBP5 (FKBP5) CSB-YP894068SWB
CSB-EP894068SWB
CSB-BP894068SWB
CSB-MP894068SWB
CSB-EP894068SWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dog Collagen alpha-1 (I) chain (COL1A1), partial CSB-YP894069DO
CSB-EP894069DO
CSB-BP894069DO
CSB-MP894069DO
CSB-EP894069DO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Equus burchelli Hemoglobin subunit alpha-1 (HBA1) CSB-YP894070EMO
CSB-EP894070EMO
CSB-BP894070EMO
CSB-MP894070EMO
CSB-EP894070EMO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×